GMO’s Q4 letter covers a number of topics, including why they believe U.S. large cap value stocks are attractive today, why they are cautious on China, and why they are tilting towards quality in U.S. small cap stocks.
Bargain, Value Trap or Something in Between?
GMO
Ben Inker, Anna Chetoukhina
Research
20 Pages
Key Takeaways
U.S. Large Value Stocks: Currently trading at the 7th percentile of historical valuations, suggesting significant upside potential if valuations revert to the mean.
U.S. Small Caps: Despite appearing inexpensive, deteriorating profitability and increased financial leverage raise concerns about their future performance.
Chinese Equities: While valuations are low, weakening fundamentals and geopolitical risks make the risk/reward profile less attractive compared to other emerging markets.